Skip to content

Clinical trials

Observational Headache trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Headache Phase: Observational Clear all

168 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20041
20055
20064
20082
20096
20104
20112
20127
20134
20147
20153
20164
20172
20186
20196
202012
202116
202217
202313
202420
202510
202614

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed82
Unknown status37
Recruiting17
Not yet recruiting11
Active, not recruiting9
Enrolling by invitation5
Withdrawn5
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Florence6
Bnai Zion Medical Center5
Allergan4
Assiut University3
Danish Headache Center3
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa3
Hospital Clínico Universitario de Valladolid3
IRCCS National Neurological Institute "C. Mondino" Foundation3
National and Kapodistrian University of Athens3
Theranica3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Headache168
Migraine Disorders70
Pain15
Headache Disorders14
Neck Pain9
Headache Disorders, Secondary8
Tension-Type Headache8
Back Pain7
Migraine with Aura7
Migraine without Aura7

Trials

Showing 51 to 75 of 168. Each trial links to its page on Pharma Observatory.

68 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.